Retreating from longstanding, common-sense measures to keep Louisianans safe from disease and protect public health is a bad ...
The Melbourne-based company on Tuesday posted what chief executive Paul McKenzie described as a robust set of half-year ...
A Moderna spokesperson told MassLive the company is preparing to advance its bird flu vaccine (mRNA-1018) into a phase 3 study, “based on the positive preliminary data from the Phase 1/2 study ...
Such a combination might provide the bird flu with the equipment it needs to pass more easily and efficiently between people. “We know for sure this virus reassorts. Nature is a giant gain-of ...
It will no longer go ahead because Labour ministers have offered less funding than their predecessors, the pharmaceutical giant said ... produce and supply our flu vaccine, for patients in ...
The vaccines business – where GSK is among the global leaders – did show a second consecutive sharp drop in sales in the fourth quarter, thanks to a 19pc decline in sales of flu jabs and a ...
Plus, a takeover bid sparks share price joy at this EV engineer Questor is The Telegraph’s stockpicking column, helping you decode the markets and offering insights on where to invest.
Pharmaceutical giant AstraZeneca has cancelled plans for a new £450m vaccine plant in Liverpool ... said the site would continue to produce flu vaccines. Last year it was reported that ...
The pharmaceutical giant announced its decision just two ... its site in Speke would "continue to produce and supply our flu vaccine, for patients in the UK and around the world".
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback